F. Hoffmann-La Roche Ltd.’s appeal from the U.S. District Court for the District of Massachusetts’ final judgment in Amgen Inc.’s lawsuit alleging infringement of its erythropoietin patents is pending with…
No appeal from the U.S. District Court for the District of Massachusetts’ Oct. 2, 2008 judgment enjoining Transkaryotic Therapies and Hoechst Marion Roussel, Inc. from infringing patents owned by Amgen…
A claims construction hearing in Amgen Inc.’s patent infringement lawsuit against Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Barr Laboratories, Inc. is set for Sept. 16 and Sept.…
Roche Diagnostics GmbH and the U.S. International Trade Commission’s motion to reconsider the ruling in Amgen Inc.’s favor is still pending before the U.S. Court of Appeals for the Federal…
Human Genome Sciences is appealing the U.S. District Court for the District of Delaware’s dismissal of a suit against Amgen Inc., which sought review of a judgment by the Board…
Shire Human Genetics Technologies Inc. continues to face Amgen Inc.’s remanded patent infringement suit in the U.S. District Court for the District of Massachusetts.
Shire Human Genetics is a subsidiary of…